ZFP101, a zinc finger protein, plays a crucial role in gene regulation, and its functional activity is modulated by a series of specific chemical activators that influence its interaction with DNA and transcription factors. Forskolin, for instance, enhances ZFP101's functional activity by increasing intracellular cAMP levels, leading to PKA activation. PKA, in turn, phosphorylates substrates that influence ZFP101's DNA-binding activity, thereby facilitating its role in gene regulation. Similarly, Curcumin, by modulating the NF-κB pathway, indirectly augments ZFP101's transcriptional repression capability. This effect is complemented by LY294002, a PI3K inhibitor, which, by altering the AKT signaling pathway, affects transcription factors and co-activators that interact with ZFP101, thereby enhancing its gene regulatory functions. Additionally, SB203580's inhibition of p38 MAPK shifts signaling towards pathways that favor ZFP101's role in stress response and inflammation gene regulation.
The second layer of ZFP101 activation involves epigenetic modulation and signal transduction pathways. Resveratrol activates SIRT1, influencing chromatin remodeling and thus enhancing ZFP101's DNA binding and regulatory efficiency. Trichostatin A and 5-Azacytidine, by altering chromatin structure through histone deacetylation inhibition and reduced DNA methylation respectively, improve ZFP101's access to DNA, enhancing its gene regulatory activity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin raises intracellular cAMP levels, which in turn activates PKA. PKA phosphorylates various substrates, including those that influence the DNA-binding activity of ZFP101, leading to its functional enhancement in gene regulation. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin modulates the NF-κB pathway, which interacts with ZFP101 in gene transcription regulation. By inhibiting NF-κB, Curcumin enhances ZFP101's role in transcriptional repression, indirectly increasing its functional activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, alters the AKT signaling pathway. This modulation indirectly enhances ZFP101 activity by affecting transcription factors and co-activators that interact with ZFP101, enhancing its gene regulatory functions. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAPK, shifting signaling towards pathways that favor ZFP101's role in gene regulation, thereby enhancing its functional activity in the context of stress response and inflammation. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol, by activating SIRT1, influences chromatin remodeling and epigenetic modifications. This activation indirectly enhances ZFP101's ability to bind to DNA and regulate gene expression more effectively. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, a histone deacetylase inhibitor, alters chromatin structure, which in turn enhances ZFP101's access to DNA and its functional activity in gene regulation. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine, a DNA methyltransferase inhibitor, reduces DNA methylation, thereby enhancing ZFP101's ability to access and regulate gene expression by altering chromatin structure. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which is involved in cellular growth and metabolism pathways. This inhibition indirectly enhances ZFP101's role in transcriptional regulation under nutrient-scarce conditions. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 inhibits MEK, which is part of the MAPK pathway. This inhibition indirectly enhances ZFP101's activity by affecting signaling cascades that influence ZFP101's gene regulatory functions. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate, a kinase inhibitor, modulates various signaling pathways, including those that interact with ZFP101, thereby indirectly enhancing its transcriptional regulatory activity. | ||||||